Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy

Vaverkova, Helena; Viigimaa, Margus; Farnier, Michel; Averna, Maurizio; Missault, Luc; Dong, Qian; Shah, Arvind; Johnson-Levonas, Amy O.; Brudi, Philippe. (2012). Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy. Cardiovascular Therapeutics, 30 (2), 61−74.10.1111/j.1755-5922.2010.00181.x.
ajakirjaartikkel
Vaverkova, Helena; Viigimaa, Margus; Farnier, Michel; Averna, Maurizio; Missault, Luc; Dong, Qian; Shah, Arvind; Johnson-Levonas, Amy O.; Brudi, Philippe.
  • Inglise
Cardiovascular Therapeutics
1755-5914
30
2
2012
6174
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

dx.doi.org/10.1111/j.1755-5922.2010.00181.x